Clinical and Biological Characteristics of Hidradenitis Suppurativa
Sponsored by University of California, San Francisco
About this trial
Last updated 3 months ago
Study ID
16-19770
Status
Recruiting
Type
Observational
Placebo
No
Accepting
13+ Years
All Sexes
Trial Timing
Started 10 years ago
What is this trial about?
Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.
What are the Participation Requirements?
Hidradenitis Suppurativa Patients Inclusion Criteria: 1. Age 13 years or older 2. Diagnosis of HS clinically-confirmed by a physician Exclusion Criteria: 1. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent. Healthy Volunteer Inclusion Criteria: 1. No history of chronic skin conditions 2. No recent history of antibiotic use Exclusion Criteria: 1. Inability to give informed consent or have a parent/guardian who is able and willing to give informed consent.